BCOP Updates 2024: Drive with Care: Updates in Adult CAR T-cell Therapy and Outpatient Administration

Type: Individual•Format: On-demand

CAR T-cell therapy is becoming a mainstay of treatment for hematologic malignancies, especially in the lymphoma and myeloma space. With continuous product approvals and advances in place in therapy, an overview and update of adult CAR T-cell therapies in the literature and associated indications is necessary, along with insight into outpatient administration, toxicity monitoring, and adverse event management.

BCOP Updates 2024: Drive with Care: Updates in CAR T-cell Therapy and Outpatient Administration

Authors:  Kelsea Seago, PharmD, BCOP; Spencer K. Yingling, PharmD, BCOP*

*All participation and contribution to this presentation regarding clinical content occurred during time in clinical practice prior to employment with Bristol Myers Squibb.

UAN#: 0465-0000-24-086-H01-P

Learning Objectives: 

  1. Discuss FDA-approved indications and recent guideline updates for CAR T-cell therapies
  2. Recognize potentially practice-changing literature associated with currently available CAR T-cell therapy products
  3. Describe novel CAR T-cell therapies under clinical trial investigation
  4. Summarize appropriate implementation policies and procedures for CAR T-cell therapy administration in an outpatient setting
  5. Compare and contrast toxicity monitoring and management strategies for CAR T-cell therapy between inpatient and outpatient settings
  6. Outline the expanding role of the oncology pharmacist in the treatment of cancers utilizing CAR T-cell therapies

Get it Now!

Knowledge Course for Pharmacist

Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.

acpe-bps-logos

HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to claim BCOP credit, you must pass the BCOP Post- Test with a 75% or higher.

All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.